Growth Metrics

Bio-Rad Laboratories (BIO) Income from Continuing Operations (2009 - 2026)

Bio-Rad Laboratories (BIO) reported Income from Continuing Operations of 527100000.0 for Q1 2026, down 923.59% year-over-year from 64000000.0 in Q1 2025, and down 173.21% on a QoQ basis from 720000000.0 in Q4 2025.

Bio-Rad Laboratories (BIO) has 18 years of Income from Continuing Operations data on file, last reported at 527100000.0 in Q1 2026.

  • Quarterly Income from Continuing Operations fell 923.59% year-over-year to 527100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 168800000.0 (up 107.8% YoY) and the FY2025 annual result came in at 759900000.0, up 141.2% from the prior year.
  • Income from Continuing Operations fell to 527100000.0 in Q1 2026 per BIO's latest filing, from 720000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 827814000.0 in Q4 2022 and bottomed at 3367315000.0 in Q1 2022.
  • The 5-year median for Income from Continuing Operations is 64000000.0 (2025), against an average of 345653882.35.
  • The widest annual swing landed in 2024, when Income from Continuing Operations soared 514.75%; it then sank 923.59% in 2026.
  • Tracing BIO's Income from Continuing Operations over 5 years: stood at 827814000.0 in 2022, then plunged by 57.75% to 349736000.0 in 2023, then plunged by 304.67% to 715800000.0 in 2024, then surged by 200.59% to 720000000.0 in 2025, then tumbled by 173.21% to 527100000.0 in 2026.
  • Per Business Quant, the three latest BIO Income from Continuing Operations figures stand at 527100000.0 (Q1 2026), 720000000.0 (Q4 2025), and 341900000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Bio-Rad Laboratories 8.23 Bn 6.66 Bn 309.40 Mn -527.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -527.10 Mn
Dec 31, 2025 720.00 Mn
Sep 30, 2025 -341.90 Mn
Jun 30, 2025 317.80 Mn
Mar 31, 2025 64.00 Mn
Dec 31, 2024 -715.80 Mn
Sep 30, 2024 653.20 Mn
Jun 30, 2024 -2.17 Bn
Mar 31, 2024 383.90 Mn
Dec 31, 2023 349.74 Mn
Sep 30, 2023 106.26 Mn
Jun 30, 2023 -1.16 Bn
Mar 31, 2023 68.96 Mn
Dec 31, 2022 827.81 Mn
Sep 30, 2022 -162.81 Mn
Jun 30, 2022 -925.11 Mn
Mar 31, 2022 -3.37 Bn
Dec 31, 2021 -1.57 Bn
Sep 30, 2021 3.93 Bn
Jun 30, 2021 914.14 Mn
Mar 31, 2021 977.41 Mn
Dec 31, 2020 847.04 Mn
Sep 30, 2020 1.31 Bn
Jun 30, 2020 966.43 Mn
Mar 31, 2020 685.91 Mn
Dec 31, 2019 553.44 Mn
Sep 30, 2019 -258.82 Mn
Jun 30, 2019 598.81 Mn
Mar 31, 2019 865.20 Mn
Dec 31, 2018 -828.49 Mn
Sep 30, 2018 269.30 Mn
Jun 30, 2018 268.04 Mn
Mar 31, 2018 656.79 Mn
Dec 31, 2017 82.70 Mn
Sep 30, 2017 22.07 Mn
Jun 30, 2017 5.04 Mn
Mar 31, 2017 12.37 Mn
Dec 31, 2016 -18.64 Mn
Sep 30, 2016 17.10 Mn
Jun 30, 2016 16.60 Mn
Mar 31, 2016 11.00 Mn
Dec 31, 2015 45.64 Mn
Sep 30, 2015 17.37 Mn
Jun 30, 2015 28.42 Mn
Mar 31, 2015 17.82 Mn
Dec 31, 2014 39.05 Mn
Sep 30, 2014 11.51 Mn
Jun 30, 2014 31.63 Mn
Mar 31, 2014 6.67 Mn
Dec 31, 2013 30.14 Mn
Sep 30, 2013 -7.10 Mn
Jun 30, 2013 34.60 Mn
Mar 31, 2013 20.17 Mn
Dec 31, 2012 43.17 Mn
Sep 30, 2012 42.62 Mn
Jun 30, 2012 48.57 Mn
Mar 31, 2012 30.94 Mn
Dec 31, 2011 59.99 Mn
Sep 30, 2011 45.86 Mn
Jun 30, 2011 40.02 Mn
Mar 31, 2011 32.94 Mn
Dec 31, 2010 67.94 Mn
Sep 30, 2010 45.09 Mn
Jun 30, 2010 38.52 Mn
Mar 31, 2010 35.39 Mn
Dec 31, 2009 38.52 Mn
Sep 30, 2009 39.30 Mn
Jun 30, 2009 59.25 Mn